Fig. 2. The trend of yearly SABA use in patients with incident asthma. (A) Percentage of subgroup patient groups categorized by the number of SABA canisters per year in patients with incident asthma after initial diagnosis. (B) Percentage of patients with SABA overuse in patients with incident asthma after initial diagnosis.
SABA, short-acting β2-agonist.